Given the close correlation between compromised mitophagy (including FUNDC1) and MASLD pathology [16, 17, 29], the possible involvement of FUNDC1‐mediated mitophagy was scrutinized in the realm of CK2α‐evoked hepatic regulation, if any. Here, FUNDC1 is linked to metabolic dysfunction-associated steatotic liver disease.